PMDA drug package insert
エフピーOD錠2.5
PMDA Prescription drug · エフピー株式会社 · package insert Feb 28, 2024
Key facts
| Brand names | エフピーOD錠2.5 |
|---|---|
| Nonproprietary names | セレギリン塩酸塩 |
| Companies | 製造販売元／エフピー株式会社 |
| Product type | Prescription drug |
| Therapeutic category | パーキンソン病治療剤（選択的MAO-B阻害剤） |
| Therapeutic category codes | 871169 |
| YJ codes | 1169010F2020 |
| Approval numbers | 21900AMX00554000 |
| Package insert edition | 第1版 |
| Package insert date | Feb 28, 2024 |
| PMDA document key | 170654_1169010F2020_1 |
| PMDA company code | 170654 |
At a glance
- 1–9 Package insert revisions
- 10–99 Related PMDA documents
- None Safety communications
- Yes PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: